![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 28, 21372-21379, July 14, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Although it is well established that estrogen
deficiency causes osteoporosis among the postmenopausal women, the
involvement of estrogen receptor (ER) in its pathogenesis still remains
uncertain. In the present study, we have generated rats harboring a
dominant negative ER
Impaired Estrogen Sensitivity in Bone by Inhibiting Both
Estrogen Receptor
and
Pathways*
§,
,
,
,
,
,
, and
§**
Department of Biochemistry, Saitama Medical
School, 38 Morohongo, Moroyama-machi, Iruma-gun, Saitama 350-0495, the
§ Department of Geriatric Medicine, Graduate School of
Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, the ¶ Department of Orthopaedic Surgery, School of Medicine,
University of Occupational and Environmental Health, 1-1 Iseigaoka,
Yahatanishi-ku, Kitakyushu 807-8555, Japan, the
YS New
Technology Institute, Inc., 519 Shimo-ishibashi, Ishibashi-machi,
Simotsuga-gun, Tochigi 329-0512, Japan, and ** CREST,
Japan Science and Technology Corporation
, which inhibits the actions of not only ER
but also recently identified ER
. Contrary to our expectation, the
bone mineral density (BMD) of the resulting transgenic female rats was
maintained at the same level with that of the wild-type littermates when sham-operated. In addition, ovariectomy-induced bone loss was
observed almost equally in both groups. Strikingly, however, the BMD of
the transgenic female rats, after ovariectomized, remained decreased
even if 17
-estradiol (E2) was administrated,
whereas, in contrast, the decrease of littermate BMD was completely
prevented by E2. Moreover, bone histomorphometrical
analysis of ovariectomized transgenic rats revealed that the higher
rates of bone turnover still remained after treatment with
E2. These results demonstrate that the prevention from the
ovariectomy-induced bone loss by estrogen is mediated by ER
pathways and that the maintenance of BMD before ovariectomy might
be compensated by other mechanisms distinct from ER
and ER
pathways.
*
This work was supported in part by research grants from the
Ministry of Education, Science and Culture of Japan; by Kanzawa Medical
Research Foundation; and by Mochida Memorial Foundation for Medical and
Pharmaceutical Research and by a Research Fellowship of the Japan
Society for the Promotion of Science for Young Scientists (JSPS) (to
S. O.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.

To whom reprint requests should be addressed: Dept. of
Geriatric Medicine, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan. Tel.: 81-3-5800-8652; Fax: 81-3-5800-6530; E-mail: inoworld-tky@umin.ac.jp.
This article has been cited by other articles:
![]() |
S. Ogawa, J. Lozach, K. Jepsen, D. Sawka-Verhelle, V. Perissi, R. Sasik, D. W. Rose, R. S. Johnson, M. G. Rosenfeld, and C. K. Glass A nuclear receptor corepressor transcriptional checkpoint controlling activator protein 1-dependent gene networks required for macrophage activation PNAS, October 5, 2004; 101(40): 14461 - 14466. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |